Type af revisorbistand:Revisionspåtegning
Navn på revisionsvirksomhed:EY Godkendt Revisionspartnerselskab
Revisionsvirksomhedens CVR-nr.:30700228
Beskrivelse af revisor:State Authorised Public Accountant
Virksomhedens regnskabsklasse:Regnskabsklasse C, mellemstor virksomhed
Grundlag for konklusion (revision):Basis for OpinionWe conducted our audit in accordance with International Standards on Auditing (ISAs) and the additionalrequirements applicable in Denmark. Our responsibilities under those standards and requirements arefurther described in the “Auditor’s Responsibilities for the Audit of the Consolidated FinancialStatements and the Parent Company Financial Statements” section of our report. We are independent ofthe Group in accordance with the International Ethics Standards Board for Accountants’ InternationalCode of Ethics for Professional Accountants (IESBA Code) and the additional ethical requirementsapplicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with theserequirements and the IESBA Code. We believe that the audit evidence we have obtained is sufficient andappropriate to provide a basis for our opinion. Material Uncertainty Related to Going ConcernWe draw attention to the material uncertainty that may cast significant doubt on the Company's ability tocontinue as a going concern. We refer to note 1 to the financial statements, which states that it is uncertainwhether additional funding can be obtained for the financing of the Company's operations and researchand development activities. However, as Management believes that such financing will be obtained, thefinancial statements have been prepared on a going concern basis. We have not modified our opinion inrespect of this matter.
Konklusion (revision):OpinionWe have audited the consolidated financial statements and the parent company financial statements ofEvaxion Biotech A/S for the financial year 1 January to 31 December 2023, which comprise a summaryof significant accounting policies, income statement, balance sheet, statement of changes in equity andnotes for both the Group the Parent Company, as well as consolidated statement of cash flows. Theconsolidated financial statements and the parent company financial statements are prepared under theDanish Financial Statements Act. In our opinion, the consolidated financial statements and the parent company financial statements give atrue and fair view of the financial position of the Group and the Parent Company at 31 December 2023,and of the results of the Group and the Company's operations as well as the consolidated cash flows forthe financial year 1 January - 31 December 2023 in accordance with the Danish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision):Statement on Management’s ReviewManagement is responsible for Management’s Review. Our opinion on the consolidated financial statements and the parent company financial statements døsnot cover Management’s Review, and we do not express any form of assurance conclusion thereon. In connection with our audit of the consolidated financial statements and the parent company financialstatements, our responsibility is to read Management’s Review and, in doing so, consider whetherManagement’s Review is materially inconsistent with the consolidated financial statements and the parentcompany financial statements or our knowledge obtained during the audit, or otherwise appears to bematerially misstated. Moreover, it is our responsibility to consider whether Management’s Review provides the informationrequired under the Danish Financial Statements Act. Based on the work we have performed, we conclude that Management’s Review is in accordance with thefinancial statements and has been prepared in accordance with the requirements of the Danish FinancialStatement Act. We did not identify any material misstatement of Management’s Review.
LoginOpret gratis brugere-conomic integration